BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36768873)

  • 1. Insulin Receptor Substrate 1 Signaling Inhibits Foxp3 Expression and Suppressive Functions in Treg Cells through the mTORC1 Pathway.
    Lee WH; Kim GE; Hong KJ; Kim HS; Lee GR
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeobox protein Hhex negatively regulates Treg cells by inhibiting Foxp3 expression and function.
    Jang SW; Hwang SS; Kim HS; Kim MK; Lee WH; Hwang SU; Gwak J; Yew SK; Flavell RA; Lee GR
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25790-25799. PubMed ID: 31792183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
    Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
    PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical stoichiometric ratio of CD4(+)  CD25(+)  FoxP3(+) regulatory T cells and CD4(+)  CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia.
    Bhattacharya K; Chandra S; Mandal C
    Immunology; 2014 May; 142(1):124-39. PubMed ID: 24354800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased suppression of CD8
    Giri PS; Dwivedi M; Begum R
    Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus aureus convert neonatal conventional CD4(+) T cells into FOXP3(+) CD25(+) CD127(low) T cells via the PD-1/PD-L1 axis.
    Rabe H; Nordström I; Andersson K; Lundell AC; Rudin A
    Immunology; 2014 Mar; 141(3):467-81. PubMed ID: 24708420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
    Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
    Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxp3 and Toll-like receptor signaling balance T
    Gerriets VA; Kishton RJ; Johnson MO; Cohen S; Siska PJ; Nichols AG; Warmoes MO; de Cubas AA; MacIver NJ; Locasale JW; Turka LA; Wells AD; Rathmell JC
    Nat Immunol; 2016 Dec; 17(12):1459-1466. PubMed ID: 27695003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function.
    Zeng H; Yang K; Cloer C; Neale G; Vogel P; Chi H
    Nature; 2013 Jul; 499(7459):485-90. PubMed ID: 23812589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool.
    Permanyer M; Bošnjak B; Glage S; Friedrichsen M; Floess S; Huehn J; Patzer GE; Odak I; Eckert N; Zargari R; Ospina-Quintero L; Georgiev H; Förster R
    Cell Mol Immunol; 2021 Feb; 18(2):398-414. PubMed ID: 33408345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression.
    Fragale A; Gabriele L; Stellacci E; Borghi P; Perrotti E; Ilari R; Lanciotti A; Remoli AL; Venditti M; Belardelli F; Battistini A
    J Immunol; 2008 Aug; 181(3):1673-82. PubMed ID: 18641303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells.
    Pinchuk IV; Beswick EJ; Saada JI; Boya G; Schmitt D; Raju GS; Brenmoehl J; Rogler G; Reyes VE; Powell DW
    Gastroenterology; 2011 Jun; 140(7):2019-30. PubMed ID: 21376048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment of rapamycin before allogenic corneal transplant promotes graft survival through increasing CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Wang X; Wang W; Xu J; Hong J; Le Q
    Exp Clin Transplant; 2013 Feb; 11(1):56-62. PubMed ID: 22769982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.
    Shenghui Z; Yixiang H; Jianbo W; Kang Y; Laixi B; Yan Z; Xi X
    Int J Cancer; 2011 Sep; 129(6):1373-81. PubMed ID: 21105040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.